Contact

About
Food Allergies and Our Approach
- Food Allergies Overview
- Our Approach and Platform
Programmes and Clinical Trials
News & Events
- News
- Events
- In the News
Menu Menu

FDA grants fast track designation to peptide-based peanut immunotherapy

24 August 2026

FDA grants fast track designation to peptide-based peanut immunotherapy

Healio
24 August 2026

https://www.aravax.com.au/wp-content/uploads/2025/09/logo-Aravax_REV.png 0 0 Admin https://www.aravax.com.au/wp-content/uploads/2025/09/logo-Aravax_REV.png Admin2026-08-24 08:00:122026-09-03 13:16:07FDA grants fast track designation to peptide-based peanut immunotherapy

© Aravax

Contact Us

Email: info@aravax.com.au

Australia

Level 9, 31 Queen St, Melbourne, Victoria, 3000 Australia
Tel: +61 (0)3 9657 0700

UK

John Eccles House, Oxford Science Park
Oxford, OX4 4GP, United Kingdom

Eight biotech companies in Melbourne you should know about ASCIA Annual Meeting, 2026